Ann Arbor, MI, United States of America

Barry Sheldon Seifer

This inventor holds 2 USPTO granted patents. Top assignee: University of Michigan. Active years: 2017-2019.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Barry Sheldon Seifer: Innovator in Medical Treatments

Introduction

Barry Sheldon Seifer is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of medical treatments, particularly in addressing hearing loss and tinnitus. With a total of 2 patents, his work reflects a commitment to improving health outcomes through innovative solutions.

Latest Patents

Seifer's latest patents include a composition and method for treating congenital cytomegalovirus induced hearing loss. This method involves administering a composition that consists essentially of a biologically effective amount of vitamin A, vitamin E, vitamin C, a vasodilator comprising magnesium, and optionally, a withanolide and/or resveratrol. Additionally, he has developed a composition and method for treating tinnitus, which follows a similar formulation to address this condition effectively.

Career Highlights

Barry Sheldon Seifer is affiliated with the University of Michigan, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on patients suffering from auditory disorders.

Collaborations

Seifer has collaborated with esteemed colleagues such as Josef M Miller and Glenn E Green, contributing to a rich environment of innovation and research.

Conclusion

Barry Sheldon Seifer's contributions to medical treatments through his patents demonstrate his dedication to enhancing patient care. His innovative approaches to treating hearing loss and tinnitus highlight the importance of research in developing effective health solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…